Skip to content
Global sound
The ReProgram

The ReProgram

GLP-1 Agonists and Longevity: The First ReProgram Scorecard

· 26 min

Show notes

🧠 Episode Overview
Are GLP-1 agonists longevity drugs?Not weight loss drugs.Not cosmetic drugs.Not simply appetite drugs.In this episode of The ReProgram, Dr. George Murphy launches a new recurring format: The ReProgram Scorecard — a science-first framework for grading popular longevity interventions through the same lens every time:Mechanistic plausibility.Human evidence.Magnitude of likely benefit.Safety and downside risk.Who may benefit most.Who should be cautious.Cost and accessibility.Longevity hype risk.And the final ReProgram grade.
🔑 Keywords
GLP-1 agonists, GLP-1 and longevity…

Website: podcasters.spotify.com

Live, last hour: 12,068 songs on 6,476 stations in 143 countries

Discover the world through radio

More ways to discover (9)

Heard something good? Save it, or open it straight away in Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
BBC Radio MerseysideContinue listening